首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery
【2h】

Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery

机译:选择性5-HT1D受体激动剂L-775606与5-HT1B / 1D受体激动剂舒马普坦和5-HT混合在人离体冠状动脉中的血管收缩作用比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AimsVasoconstriction in human coronary artery can be mediated via activation of both 5-HT2 and 5-HT1B-receptors. Coronary vasoconstriction is a rare, but potential adverse effect of the antimigraine drug sumatriptan. In order to investigate the receptor population involved we compared the vasoconstrictor effects of sumatriptan (a mixed 5-HT1B/1D-receptor agonist) with those of L-775,606 (a selective 5-HT1D-receptor agonist) and 5-HT (the endogenous ligand) in human isolated coronary arteries.
机译:人冠状动脉的血管收缩可以通过5-HT2和5-HT1B受体的激活来介导。冠状动脉血管收缩术是一种罕见的抗偏头痛药物舒马曲坦的潜在不良反应。为了研究所涉及的受体群体,我们比较了舒马曲坦(一种混合的5-HT1B / 1D受体激动剂)与L-775,606(一种选择性的5-HT1D受体激动剂)和5-HT(内源性)的血管收缩作用配体)在人类孤立的冠状动脉中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号